Daryl Shane De Mesa

Rolapitant reduces nausea and vomiting in Phase III trial

Rolapitant reduces nausea and vomiting in patients receiving cisplatin-based chemotherapy, according to the results of a phase III trial presented for the first time today at the ESMO 2014 Congress in Madrid, Spain.

Genetic 'instruction set' for antibodies knocks down hepatitis C in mice

A triple-punch of antibodies both prevented hepatitis C infection and wiped out the disease after it had established itself in laboratory mice, according to a study led by Princeton University researchers. Instead of delivering the three antibodies directly, the researchers administered a genetic "instruction set" that, once in a cell, developed into antibodies that target the portions of the virus that do not mutate.

NOT ALL HISPANICS ARE THE SAME WHEN IT COMES TO DRINKING

Hispanics are often grouped into a single category when it comes to alcohol use. Yet a new Michigan State University study indicates that the risk of alcohol abuse and dependence can vary significantly among different subgroups within the population.
1 2 3 4 5 6 7 8 9 10  

Recommended Stories

Real Time Analytics